Sr. No.	Received from	Pending at the end of last month	Received	Resolved*	Total Pending #	Pending complaints >3months	Average Resolution time^ (in days)
1	Directly from Investors	0	0	0	0	0	0
2	SEBI (SCORES)	0	0	0	0	0	0
3	Other Sources (if any)	0	0	0	0	0	0
	Grand Total	0	0	0	0	0	0

Sr. No.	Month	Carried forward from previous month	Received	Resolved*	Pending#
1	Jun, 2026	0	0	0	0
2	Jul, 2026	0	0	0	0
3	Aug, 2026	0	0	0	0
	Grand Total	0	0	0	0

Sr. No.	Fin. Year	Received	Resolved*
1	2022-23	1	1
2	2023-24	0	0
3	2024-25	0	0
4	2025-26	1	1
	Grand Total	2	2

Top Pharma Companies in India by Market Cap

BSE Sensex 75550.42 1090.89 (1.47%)

Filter

Top Pharma Companies in India as on Nov-2026 | 5 Star Rated Stocks Undervalued Stocks Fair Valued Stocks Uptrend Stocks

Filter

Expand company details	Company Name	DeciZen	Market cap (Rs. Cr.)	CMP (Change %)	Latest P/E	Latest P/BV	5Y Sales Gr.(%)	5Y Profit Gr.(%)	More company information
61	Indegene Ltd.	Q V+ PT	14,164 Small Cap	622.10 (5.86%)	34.45	4.22	29.44	13.80	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
62	Indoco Remedies Ltd.	Q V+ PT	1,923 Small Cap	214.65 (3.02%)	60.22	1.88	8.25	-199.84	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
63	Indraprastha Medical Corporation Ltd.	Q V PT	2,797 Small Cap	313.05 (2.59%)	N/A	N/A	0.00	0.00	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
64	Innova Captab Ltd.	Q V PT	5,900 Small Cap	1,023.90 (-0.70%)	37.75	5.2	31.75	26.73	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
65	IOL Chemicals And Pharmaceuticals Ltd.	Q V+ PT	5,217 Small Cap	178.60 (0.48%)	25.68	2.71	0.00	0.00	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
66	Ipca Laboratories Ltd.	Q V+ PT	48,907 Mid Cap	1,966 (1.99%)	39.32	5.86	7.35	1.36	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
67	Jagsonpal Pharmaceuticals Ltd.	Q V+ PT	1,433 Small Cap	216.50 (-0.18%)	N/A	N/A	0.00	0.00	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
68	Jubilant Pharmova Ltd.	Q V+ PT	14,729 Small Cap	924.05 (-0.07%)	41.83	2.07	6.31	-7.74	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
69	Jupiter Life Line Hospitals Ltd.	Q V PT	8,402 Small Cap	263.40 (2.77%)	45.07	5.15	25.27	0.00	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
70	Kilitch Drugs (India) Ltd.	Q V PT	703 Small Cap	206.15 (2.56%)	23.38	2.5	28.00	58.07	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
71	KMC Speciality Hospitals (India) Ltd.	Q V PT	2,422 Small Cap	147.95 (-0.37%)	N/A	N/A	0.00	0.00	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
72	Kopran Ltd.	Q V PT	1,156 Small Cap	244.20 (2.05%)	46.29	2.16	6.74	-8.11	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
73	Kovai Medical Center & Hospital Ltd.	Q V PT	6,356 Small Cap	5,734.45 (-1.27%)	24.8	4.58	18.09	25.97	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
74	Krishna Institute of Medical Sciences Ltd	Q V PT	29,480 Small Cap	714.85 (1.84%)	144.3	7.79	24.04	3.67	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
75	Krsnaa Diagnostics Ltd.	Q V+ PT	1,635 Small Cap	506.65 (0.51%)	16.78	1.65	0.00	0.00	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
76	Kwality Pharmaceuticals Ltd.	Q V+ PT	3,604 Small Cap	3,511.15 (1.08%)	44.47	10.11	13.94	34.90	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
77	Laurus Labs Ltd.	Q V+ PT	1,29,243 Mid Cap	2,380 (-0.50%)	96.46	21.33	7.19	-2.25	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
78	Laxmi Dental Ltd.	Q V PT	978 Small Cap	179 (0.70%)	31.67	3.99	0.00	0.00	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
79	Lincoln Pharmaceuticals Ltd.	Q V PT	1,005 Small Cap	504.60 (0.53%)	10.38	1.24	9.61	3.24	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
80	Lupin Ltd.	Q V PT	91,870 Mid Cap	2,027.70 (0.93%)	16.62	3.86	13.02	32.37	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
81	Manipal Health Enterprises Ltd.	Q V+ PT	87,926 Mid Cap	644.80 (-3.54%)	98.54	5.3	41.64	0.00	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
82	Mankind Pharma Ltd.	Q V PT	1,02,797 Mid Cap	2,510.55 (0.88%)	45.84	5.85	18.10	8.40	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
83	Marksans Pharma Ltd.	Q V+ PT	13,896 Small Cap	310 (1.09%)	26.89	4.37	16.48	7.89	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
84	Max Healthcare Institute Ltd.	Q V PT	83,706 Mid Cap	900 (4.65%)	60.63	7.39	27.27	155.29	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
85	Medicamen Biotech Ltd.	Q V+ PT	359 Small Cap	256.85 (0.53%)	33.18	1.26	11.90	-6.38	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
86	Medico Remedies Ltd.	Q V+ PT	155 Small Cap	19.24 (3.16%)	N/A	N/A	0.00	0.00	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
87	Metropolis Healthcare Ltd.	Q V PT	11,310 Small Cap	551.10 (1.09%)	56.09	7.25	10.52	0.55	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
88	Morepen Laboratories Ltd.	Q V+ PT	6,230 Small Cap	108.05 (-4.97%)	33.04	4.51	8.73	-11.54	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
89	Narayana Hrudayalaya Ltd.	Q V PT	35,144 Small Cap	1,840.30 (7.01%)	40.92	7.02	25.04	0.00	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
90	Natco Pharma Ltd.	Q V+ PT	15,350 Small Cap	784.75 (0.29%)	13.41	1.45	14.72	28.08	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
Prev 1 2 3 4 5 Next

Screens:

AlphaCases Top Rated Stocks Best Nifty Stocks Best Nifty Next Stocks Best Nifty 500 Stocks Best SmallCap Stocks Top BFSI Stocks

Pharma - Today's Top Gainers

Company Name	CMP	Price Change(%)
Narayana Hrudayalay.	1,840.30	7.01%
Advanced Enzyme Tech	279.60	6.33%
Indegene	622.10	5.86%
Themis Medicare	99.84	5.09%
Max Healthcare Inst.	900	4.65%

Pharma - Today's Top Losers

Company Name	CMP	Price Change(%)
Sigachi Industries	25.02	-5.23%
Morepen Laboratories	108.05	-4.97%
Concord Biotech	1,188	-4.60%
Bliss GVS Pharma	623	-3.92%
Artemis MedicareServ	281.55	-3.64%

News about Top Pharma Companies in India

Nov, 2026

IOL Chemicals and Pharmaceuticals submits investor presentation

IOL Chemicals and Pharmaceuticals has informed that it enclosed the Investor Presentation on the Financial Results of the Company for the quarter and half year ended 30th September 2026. This presentation is being submitted in compliance with Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended. This presentation is also made available on the Company’s website www.iolcp.com.

The above information is a part of company’s filings submitted to BSE.

Nov, 2026

IOL Chemicals and Pharmaceuticals submits newspaper publication

Pursuant to the Regulation 47 and other applicable provisions of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, IOL Chemicals and Pharmaceuticals has informed that it enclosed copies of the newspaper publication of un-audited Financial Results for the quarter and half year ended 30th September 2026 published in Business Standard, Economic Times, Financial Express, and Punjabi Jagran on 31st October 2026.

The above information is a part of company’s filings submitted to BSE.

Oct, 2026

Indegene informs about newspaper advertisement

Pursuant to Regulation 47 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Indegene has informed that it enclosed copies of the newspaper advertisement published in Financial Express (English) and Vishwavani (Kannada) today, relating to financial results for 2nd quarter and half year ended September 30, 2026. The above information will be made available on the website of the Company: https://www.indegene.com/.

The above information is a part of company’s filings submitted to BSE.

Oct, 2026

Manipal Health Enterprises informs about disclosure

Manipal Health Enterprises has informed that it enclosed Disclosures of reasons for encumbrance by promoter of listed companies under Reg. 31(1) read with Regulation 28(3) of SEBI (SAST) Regulations, 2011 on October 30, 2026 for MEMG International India.

The above information is a part of company’s filings submitted to BSE.

Oct, 2026

Max Healthcare Inst. - Quaterly Results

The company witnessed a 14.30% growth in the revenue at Rs. 8419.70 millions for the quarter ended September 2026 as compared to Rs. 7366.20 millions during the year-ago period.Profit for the quarter ended September 2026 grew by 4.93% to Rs. 1683.30 millions from Rs. 1604.20 millions.Operating profit surged to 2786.40 millions from the corresponding previous quarter of 2611.00 millions.

(Rs. in Million)

	Quarter ended			Year to Date			Year ended
	202609	202509	% Var	202609	202509	% Var	202603	202503	% Var
Sales	8419.70	7366.20	14.30	16248.90	14306.40	13.58	28744.50	26636.00	7.92
Other Income	491.10	474.30	3.54	1412.10	1272.80	10.94	3019.50	3665.40	-17.62
PBIDT	2786.40	2611.00	6.72	5532.20	5286.60	4.65	11225.30	11999.30	-6.45
Interest	137.20	86.70	58.25	257.90	179.20	43.92	398.70	483.90	-17.61
PBDT	2649.20	2524.30	4.95	5274.30	5107.40	3.27	10670.20	10779.10	-1.01
Depreciation	387.70	367.70	5.44	753.70	722.00	4.39	1429.00	1311.90	8.93
PBT	2261.50	2156.60	4.86	4520.60	4385.40	3.08	9241.20	9467.20	-2.39
TAX	578.20	552.40	4.67	1161.30	1120.90	3.60	2075.10	2456.50	-15.53
Deferred Tax	-28.30	50.80	-155.71	-17.10	77.10	-122.18	196.70	482.90	-59.27
PAT	1683.30	1604.20	4.93	3359.30	3264.50	2.90	7166.10	7010.70	2.22
Equity	9733.10	9722.40	0.11	9733.10	9722.40	0.11	9731.30	9721.40	0.10
PBIDTM(%)	33.09	35.45	-6.64	34.05	36.95	-7.86	39.05	45.05	-13.31

Oct, 2026

Narayana Hrudayalay. - Quaterly Results

The revenue zoomed 16.31% to Rs. 11853.77 millions for the quarter ended September 2026 as compared to Rs. 10191.69 millions during the corresponding quarter last year.Good Net Profit growth of 27.38% reported above the corresponding previous quarter figure of Rs. 1378.80 millions to Rs. 1756.26 millioins.Operating profit for the quarter ended September 2026 rose to 3045.61 millions as compared to 2461.39 millions of corresponding quarter ended September 2025.

(Rs. in Million)

	Quarter ended			Year to Date			Year ended
	202609	202509	% Var	202609	202509	% Var	202603	202503	% Var
Sales	11853.77	10191.69	16.31	22824.79	19623.10	16.32	39751.41	35901.22	10.72
Other Income	433.50	170.88	153.69	737.63	335.24	120.03	1764.34	1421.63	24.11
PBIDT	3045.61	2461.39	23.74	5740.96	4415.93	30.01	10158.82	8137.02	24.85
Interest	352.30	285.78	23.28	688.96	592.01	16.38	1271.16	877.08	44.93
PBDT	2693.31	2175.61	23.80	5052.00	3823.92	32.12	8434.90	7259.94	16.18
Depreciation	501.09	462.66	8.31	982.57	938.24	4.72	1914.78	1692.63	13.12
PBT	2192.22	1712.95	27.98	4069.43	2885.68	41.02	6520.12	5567.31	17.11
TAX	435.96	334.15	30.47	934.62	633.17	47.61	1488.99	1255.89	18.56
Deferred Tax	17.03	18.36	-7.24	34.58	30.77	12.38	-75.93	187.21	-140.56
PAT	1756.26	1378.80	27.38	3134.81	2252.51	39.17	5031.13	4311.42	16.69
Equity	2043.61	2043.61	0.00	2043.61	2043.61	0.00	2043.61	2043.61	0.00
PBIDTM(%)	25.69	24.15	6.39	25.15	22.50	11.77	25.56	22.67	12.75

Top 10 Publicly Listed pharmaceutical stocks in India by Market Capitalization as of 2026.

Rank	Company	Market Capitalization 2026 (INR crores)
1	3B Blackbio Dx Ltd.	1,113 Crore
2	Aarti Drugs Ltd.	3,977 Crore
3	Aarti Pharmalabs Ltd.	7,922 Crore
4	Abbott India Ltd.	54,384 Crore
5	Acutaas Chemicals Ltd.	32,770 Crore
6	Advanced Enzyme Technologies Ltd.	2,944 Crore
7	Ajanta Pharma Ltd.	43,891 Crore
8	Akums Drugs & Pharmaceuticals Ltd.	11,520 Crore
9	Alembic Pharmaceuticals Ltd.	15,682 Crore
10	Alivus Life Sciences Ltd.	17,311 Crore

Do you know? Asking 3 Right Questions minimizes the RISK of Stock Investing To Know

Right Stock | Right Price | Right Allocation

Find best stocks to buy now Find best pharma stocks to buy now

Top 15 Pharma Stocks by Revenue Growth

Top Pharma Companies Source: NSE Indices

You can use different criterias to arrive at the list of best stocks in the Nifty Pharma company index. You can use return ratios like ROCE or ROE, that will help you choose companies with profitable growth.

Based on ROE, the best stocks in the Nifty Pharma companies index are:

Company Name	Is it a Right Stock ?	CMP	Market Cap(Cr.)	P/E	P/BV	EV/EBITDA	ROE
Abbott India Ltd. (M)	Very Good	25,731	54,384	33.68	10.51	23.07	34.24
Torrent Pharmaceuticals Ltd. (L)	Very Good	4,598	1,76,306	83.01	9.60	33.08	29.04
Glenmark Pharmaceuticals Ltd. (M)	Very Good	2,390	65,137	36.23	5.94	12.08	27.89
Lupin Ltd. (M)	Somewhat Good	2,028	91,870	16.62	3.86	9.20	26.43
Ajanta Pharma Ltd. (M)	Very Good	3,426	43,891	34.76	9.03	23.33	25.35

Based on the past year's gain, the best performing stocks are:

Company Name	Is it a Right Stock ?	CMP	Market Cap(Cr.)	Yearly gain (%)
Laurus Labs Ltd. (M)	Very Good	2,380	1,29,243	147
Sai Life Sciences Ltd. (S)	Somewhat Good	1,550	33,139	69.37
Gland Pharma Ltd. (M)	Very Good	3,069	51,112	61.94
Aurobindo Pharma Ltd. (M)	Very Good	1,668	96,537	52.18
Ipca Laboratories Ltd. (M)	Very Good	1,966	48,907	49.58
				View More

Stocks with the highest revenue growth in the past 5 years is:

Company Name	Is it a Right Stock ?	CMP	Market Cap(Cr.)	P/E	P/BV	EV/EBITDA	5Y Sales Growth (%)
Sai Life Sciences Ltd. (S)	Somewhat Good	1,550	33,139	91.61	12.98	47.25	23.61
Mankind Pharma Ltd. (M)	Very Good	2,511	1,02,797	45.84	5.85	24.28	18.10
Ajanta Pharma Ltd. (M)	Very Good	3,426	43,891	34.76	9.03	23.33	13.54
Zydus Lifesciences Ltd. (M)	Very Good	1,239	1,24,089	27.50	4.60	15.32	13.52
Gland Pharma Ltd. (M)	Very Good	3,069	51,112	45.28	4.81	23.17	13.18

Stocks with high profit growth often witness their stock prices gaining, irrespective of the market movements.

Stocks with the highest profit growth in the past 5 years is:

Company Name	Is it a Right Stock ?	CMP	Market Cap(Cr.)	P/E	P/BV	EV/EBITDA	5Y Profit Growth (%)
Sai Life Sciences Ltd. (S)	Somewhat Good	1,550	33,139	91.61	12.98	47.25	39.96
Lupin Ltd. (M)	Somewhat Good	2,028	91,870	16.62	3.86	9.20	32.37
Glenmark Pharmaceuticals Ltd. (M)	Very Good	2,390	65,137	36.23	5.94	12.08	22.19
Abbott India Ltd. (M)	Very Good	25,731	54,384	33.68	10.51	23.07	17.33
Dr. Reddys Laboratories Ltd. (M)	Very Good	1,357	1,12,699	40.25	2.90	18.79	15.75

Name of the IA registered with SEBI:	The Alchemists Ark Pvt. Ltd.
Logo:
Trade/Brand Name of IA:	MoneyWorks4Me Investment Advisers
Brand Logo:
SEBI Registration Number:	INA000013323 Validity – May 16, 2019 – Perpetual
Registration:	Non-Individual
BSE Enlistment No:	1187
Address:	B-101, Signet Corner Building, Balewadi Phata, Baner, Pune, Maharashtra 411045

Compliance Officer Details:	Name: Shrikant Jagtap Email: shrikant.jagtap@moneyworks4me.com	Telephone: +919860359463 Address: Same as IA
Grievance Officer Details:	Name: Mukta Vaze Email: mukta.vaze@moneyworks4me.com	Telephone: +919860919463 Address: Same as IA
Principal Officer Details:	Name: Atharva Bhide Email: atharva.bhide@moneyworks4me.com	Telephone: +919175899463 Address: Same as IA
Standard Warning:	Investment in securities market are subject to market risks. Read all the related documents carefully before investing.
Disclaimer:	Registration granted by SEBI, enlistment with exchange and certification from NISM in no way guarantee performance of the intermediary or provide any assurance of returns to investors.

Current Complaints

*Inclusive of complaints of previous months resolved in the current month. #Inclusive of complaints pending as on the last day of the month.

*Inclusive of complaints of previous months resolved in the current month. #Inclusive of complaints pending as on the last day of the year.

Top Pharma Companies in India by Market Cap

News about Top Pharma Companies in India

IOL Chemicals and Pharmaceuticals submits investor presentation

IOL Chemicals and Pharmaceuticals submits newspaper publication

Indegene informs about newspaper advertisement

Manipal Health Enterprises informs about disclosure

Max Healthcare Inst. - Quaterly Results

Narayana Hrudayalay. - Quaterly Results

Publicly traded pharmaceuticals

Top 10 Publicly Listed pharmaceutical stocks in India by Market Capitalization as of 2026.

Top 15 Pharma Stocks by Revenue Growth

Top Pharma Companies Source: NSE Indices

How to select the top Nifty Pharma stocks based on RoE?

What are the best-performing stocks in the Nifty Pharma index?

Which Nifty Pharma stocks have the highest revenue growth in the past five years?

Which Nifty Pharma stocks had the highest profit growth in the past five years ?